anti-Serum Albumin (human), mAb (1G2)

CHF 315.00
In stock
YIF-LF-MA0106100 µlCHF 315.00
More Information
Product Details
Synonyms ALB; Serum Albumin
Product Type Monoclonal Antibody
Clone 1G2
Isotype Mouse IgG1 κ
Immunogen/Antigen Purified human serum albumin protein.

Western Blot (1:2,000)
Immunoprecipitation (1 μl)

Crossreactivity Human
Purity Detail Ammonium sulfate precipitation.
Formulation Liquid. HEPES with 0.15M NaCl, 0.01% BSA, 0.03% sodium azide, and 50% glycerol.
Isotype Negative Control

Mouse IgG1 Isotype Control

Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by AbFrontier
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF

Human serum albumin (HSA) is the most abundant protein in mammalian plasma and is generally considered to be a multifunctional transport protein. HSA is a signle-chain protein synthesized in and secreted from liver cells. HSA has significant antioxidant activity and may represent the major and predominant circulating antioxidant in plasma, which is known to be exposed to continuous oxidative stress. HSA protects human low density lipoproteins against copper-mediated oxidation and blood against hemolysis by free radicals. HSA which are exposed to glucose and have a relatively slow turnover rate are particularly susceptible to nonenzymatic glycosylation. Structural changes in glycosylated albumin lead to a reduction in affinity for fatty acid. Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca2+, Na+, K+, fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.

Product References

1) Keisuke Nakajou et al. (2003) Biochimica et Biophysica Acta 1623:88-97. (General)
2) Makoto Anraku et al. (2001) Pharmaceutical Research 18(5):632-639. (General)
3) Nurith Shaklai et al. (1984) The Journal of Biological Chemistry 259(6):3812-3817. (General)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.